某儿童医院人血白蛋白合理用药专项点评及改进策略  

Special Evaluation and Intervention Analysis of Rational Use of Human Serum Albumin in a Children's Hospital

作  者:谢奕伟 黄强增 XIE Yiwei;HUANG Qiangzeng(Children's Hospital,the First General Hospital of Fuzhou City,Fuzhou 350000,Fujian,China)

机构地区:[1]福建省福州市第一总医院儿童专科院区,福建福州350000

出  处:《中国药物滥用防治杂志》2025年第1期55-57,73,共4页Chinese Journal of Drug Abuse Prevention and Treatment

摘  要:目的:分析某儿童医院人血白蛋白使用情况,发现存在的问题并提出改进建议。方法:调取某儿童医院出院日期为2023年1月1日—12月31日且接受人血白蛋白治疗的全部儿童患者数据89例,分析人血白蛋白应用情况及不合理用药的原因。结果:人血白蛋白的合理使用率为73.03%,不合理率达到26.97%。外科不合理用药使用率高于内科(P<0.05),主要是术中和术后过度使用白蛋白,缺乏足够的适应证或生化证据支持。结论:临床实践中存在着一些不合理使用人血白蛋白的现象,尤其在外科领域尤为突出。因此,需加强对人血白蛋白使用培训,建立系统的审方机制,优化用药流程,强化多学科合作,确保人血白蛋白的合理、有效和安全使用。Objective:To analyze the use of human serum albumin in a children's hospital,find out the existing problems and put forward suggestions for improvement.Methods:The data of 89 children who were discharged from a children's hospital from January 1,2023 to December 31,2023 and treated with human serum albumin were collected,and the application of human serum albumin and the reasons for irrational drug use were analyzed.Results:The reasonable utilization rate of human albumin was 73.03%,and the unreasonable rate was 26.97%.The rate of irrational drug use in surgery was higher than that in internal medicine(P<0.05),mainly due to excessive use of albumin during and after surgery,and lack of sufficient indications or biochemical evidence.Conclusion:There are some unreasonable use of human albumin in clinical practice,especially in the field of surgery.Therefore,it is necessary to strengthen the training on the use of human albumin,establish a systematic prescription review mechanism,optimize the medication process,and strengthen multidisciplinary cooperation to ensure the rational,effective and safe use of human albumin.

关 键 词:人血白蛋白 血清白蛋白水平 合理用药 儿童医院 

分 类 号:R96[医药卫生—药理学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象